Table 4.
Mycotoxins | Groups | Total | Workers | Controls | p Value |
---|---|---|---|---|---|
DON-GlcA | Not exposed | 18 (40.9%) | 10 (40.0%) | 8 (42.1%) | 1 * |
Exposed | 26 (59.1%) | 15 (60.0%) | 11 (57.9%) | ||
AFM1 | Not exposed | 39 (88.6%) | 21 (84.0%) | 18 (94.7%) | 0.370 ** |
Exposed | 5 (11.4%) | 4 (16.0%) | 1 (5.3%) | ||
CIT | Not exposed | 31 (70.5%) | 23 (92.0%) | 8 (42.1%) | 0.001 * |
Exposed | 13 (29.5%) | 2 (8.0%) | 11 (57.9%) | ||
DH-CIT | Not exposed | 39 (88.6%) | 22 (88.0%) | 17 (89.5%) | 1 ** |
Exposed | 5 (11.4%) | 3 (12.0%) | 2 (10.5%) | ||
EnB | Not exposed | 41 (93.2%) | 24 (96.0%) | 17 (89.5%) | 0.57 ** |
Exposed | 3 (6.8%) | 1 (4.0%) | 2 (10.5%) | ||
OTA | Not exposed | 11 (25.0%) | 5 (20.0%) | 6 (31.6%) | 0.598 * |
Exposed | 33 (75%) | 20 (80.0%) | 13 (68.4%) |
* Chi-Square Test of Independence; ** Fisher Exact Test.